PMA PI and Deputy Dean MakSPH Dr. Frederick Makumbi (R), Dr. Richard Mugahi Adyeeri, the Assistant Commissioner in charge of Reproductive and Infant Health (2nd R) and Dr. Simon Peter Kibira, the PMA Uganda Co-Principal Investigator (L) chat with another official at the dissemination of panel survey results for phase 2 on 16th February 2022, Golden Tulip Hotel, Kampala.
Kampala, Uganda, Feb. 16, 2022 (MakSPH) – Commissioners at Ministry of Health in Uganda have applauded the Performance Monitory for Action -PMA Uganda project for its robust research in family planning.
Dr. Olaro Charles, the Director Health Services- Curative Services at the Ministry of Health says the Ministry is grateful for the work that PMA does, citing that it would cost government a lot of money since such work would require a consultant to do it.
“The data collected in this PMA survey inform monitoring and assessment, assessing the progress of the targets as we set in the Family Planning 2030 commitments and the costed implementation plan. I am happy that all of you were involved during the formulation and official launch of these commitments,” Dr. Olaro said at a recent dissemination of panel survey results for phase 2 at Golden Tulip Hotel in Kampala.
PMA Uganda, a Bill and Melinda Gates Foundation funded project at Makerere University School of Public Health (MakSPH), a leading public health institution in Uganda and within the East and Central Africa region uses innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators.
Between September and November last year, MakSPH-PMA project led by Principal Investigator Dr. Fredrick Makumbi and Co-Principal Investigator Dr. Simon Peter Kibira conducted a survey from 4,399 households where 4,346 females of ages 15-49 were interviewed. Also, data was collected in 384 health facilities and 2,370 client-exit interviews conducted.
According to the results, the trends in use of Contraception among all women of age 15-49 increased from 35% in 2020 to 40% in 2021 in all methods. On further analysis, those using modern methods of contraception increased from 29.5% to 34% while those using traditional methods of birth control rose slightly from 5.5% in 2021 to 5.9%.
“I am also happy to mention that I sit in the FP20 global committee, and as you know this is great not only for our country but as well as the region. From the first PMA survey, we were seeing the country making progress, however slow it is towards increasing modern contraceptive usage. As you all know the FP2030 objectives were launched and we need to be able to work. I will soon share with you the considerable plan, which is also a precursor for us to be able to achieve our Family Planning 2020,” said Dr. Olaro.
The Government of Uganda set an ambitious goal to increase the modern contraceptive prevalence rate to 50% by 2020. This however was not achieved. In acknowledging this, Dr. Olaro notes that there are still unsolved challenges with the quality of family planning services especially the counselling of users.
“If you go to back to our commitments, one of them is purposed to address this challenge. To address family planning misconceptions, government committed to improve counselling and in it, we provide what options are available, possible side effects and how we manage them, and how the users pick on a different component. So, with implementation and measurements, we shall be able to overcome the challenge,” says Dr. Olaro.
Hons. Catherine Namuddu, Sylivia Bahireira, Joel Ssebikaali, Charles Ayume, Hope Nakazibwe, Ronald Bagaga and Bayiga Rulume, all Members of the Health Committee of Parliament attended the dissemination.
Professor of Disease Control, Researcher, Public Health Expert and Dean, MakSPH, Dr. Rhoda Wanyenze says a lot of the work that done at MakSPH is geared towards ensuring equity and through evidence. According to Prof. Wanyenze, PMA program is one of the projects at MakSPH where researchers generate evidence and continue facilitating policy formulation.
“This program shows this because on the data we have generated, has to be used by all these stake holders here with us today. For example, we have just used the PMA data to inform Uganda’s FP2030 commitments and before that we were also looking at this data while implementing the costed development plan,” she said.
Professor of Disease Control, Researcher, Public Health Expert and Dean, MakSPH, Dr. Rhoda Wanyenze
Speaking to an audience that had legislators under the umbrella of the Health Committee of Parliament, Professor Wanyenze said improving health requires holistic approach that includes several other sectors of development including education. She also appealed to the legislators and the sector planners to re-orient health by investing more in promotion of health and prevention of disease than focus only at treating people.
“We can also generate more evidence. You can tell us where it is that you need more evidence that you do not have so that we can work together to generate evidence. We are available and ready to work with you so you can make more evidence-based interventions,” she said.
In light of the Makerere University centenary celebrations, Dean Rhoda pledged continued generation of evidence that adds value.
Dr. Olaro paid emphasis on need for concerted efforts of Ministry of Health an its partners required to solve family planning challenges.
“We need to develop and adopt the use of innovative strategies to inform programming in an effort to address some, if not most of these challenges and I want to implore you to implement what works based on the findings,” Dr. Olaro said.
Further adding that; “These statistics that guide in programming should be progressively pursued and we are looking forward to continue good working relationships as we strive for better health of our communities in which we serve and live.”
Dr. Richard Mugahi Adyeeri, the Assistant Commissioner in charge of Reproductive and Infant Health said MoH appreciates Dean Rhoda’s comments especially the call for evidenced based Interventions and the ability of the ivory tower, to keep producing this evidence whenever it is needed.
“We also appreciate your comment about the partnership with education, given the fact that the determinants of health, some of them fall in education, others are housed in agriculture, and we need a total rethink of our post pandemic public health interventions,” Dr. Mugahi observes.
Dr. Richard Mugahi Adyeeri, the Assistant Commissioner in charge of Reproductive and Infant Health shares with the PMA PI and Deputy Dean MakSPH Dr. Frederick Makumbi
He encouraged research entities to continuously share information and best practices, as well as coordinate research efforts across different agencies. He also committed on behalf of UBOS to continue working together with MakSPH.
“The Dean has talked about the need to utilise information. There is a lot of information that is collected, but probably not much is being used but looking at the audience in here, I am encouraged and feel contented that the information is getting as far as the parliament because it influences policy and the fact that within the audience we have the policy makers, to me it is a testimony and really important,” said Muwonge.
National Population Council (NPC) Director General, Dr. Jotham Musinguzi said they advised Parliament on the need to invest in the population, reduce fertility in this country, and investments in education as a means to reduction of fertility.
NPC was established by the National Population Council, Act 485, 1994, to advise Government on all population matters. Dr. Musinguzi observes that if we do not reduce fertility fast enough, we will not be able to benefit from the demographic dividend.
“We have an opportunity now that Fredrick (Makumbi) and Simon (Kibira) have shown us that we can impact on contraceptive work, we can push it firmly, we need to make sure that education, health are working together so that the population moves from a pyramid that is very heavy at the bottom, to a pyramid that has a lot of people in the middle and these people get education, health and have skills,” he said.
In the last decade, Dr. Musinguzi says Uganda has been reducing on mortality and fertility rates citing that that’s when the country enters the realm of opportunity.
“I want say that this is something very important and we need to continue leaning to reproductive health and family planning especially use of contraceptives and through working with the Ministry of Health and other development partners. That is the only way we are going to achieve big impact on health, education of the population,” he said.
Dr. Betty Kyadondo, the head of Family Health Department at NPC noted that while there was an increase in the uptake of family planning services and that modern contraceptives, the country still needed to do more.
She says great attention to the issues of use of contraceptive by certain groups such as adolescents and men, that are largely under looked and misrepresented is important.
“They don’t get adequate counselling in times they need the service but we are seeing an increasing number of teenage pregnancy rates and if we don’t work with these young people, its risky and sensitive issue and many people are shy to talk about it but its high time we faced it and addressed sexually active adolescents about the use of family planning methods,” Dr. Kyadondo says.
She advances the need to leverage on the existing efforts in improving family planning service delivery such as human capital development program, community mobilisation and mindset change to reduce negativity and misconceptions about family planning, utilization of the parish development model through its pillars as well as integration of integrate technology into our family planning agenda.
The Sanger Prize presents a wonderful opportunity for genomics students in low and middle income countries, therefore the prize administrators are keen for the application information to reach as many eligible people as possible.
A Voice for Excellence, Equity and African Sovereignty
When Dr. Michael Makanga walked onto the stage at the 8th Galien Forum Africa in Dakar on 31 October 2025 to receive the Special Career Achievement Galien Prize, presented by President Bassirou Diomaye Faye under the theme Health sovereignty: an imperative for Africa, the moment carried weight beyond any medal or citation. “It is a celebration of a lifelong commitment,” he said, “but also a reminder of a responsibility I have never been willing to compromise: to inspire others to raise their voices for excellence, science, and equity.”
For more than two decades, Dr. Makanga has been a quiet architect of Africa’s health sovereignty. His work has unfolded far from cameras: in laboratories constrained by resources, in policy rooms where African priorities demanded a stronger voice, and in mentoring sessions with young scientists seeking reassurance that their ideas mattered.
Born and trained in Uganda, Dr. Makanga earned a Bachelor of Medicine and Surgery from Makerere University before pursuing a master’s degree and PhD at the Liverpool School of Tropical Medicine. His career spans nearly 30 years, encompassing tropical medicine, clinical trials in Africa and Europe, and senior international management roles. Since joining EDCTP in 2004, he has guided its growth as a unique Africa–Europe partnership, strengthening African capacity for high-quality, ethical clinical research while accelerating solutions for poverty-related diseases. Today, he leads the Global Health EDCTP3 Joint Undertaking under the EU’s Horizon Europe programme.
President Faye captured the essence of Dr. Makanga’s achievement: “Scientific excellence is not negotiable; it is earned. It underpins our credibility and our sovereignty.” For Dr. Makanga, the statement is a call to action. “I hope this recognition reminds us that Africa’s scientists and innovators can lead global health research with excellence and purpose. We owe it to the next generation to build the systems and confidence that make this possible,” he said.
Dr. Makanga’s peers describe him as a “builder”: someone who strengthens research systems, mentors emerging scientists, and fosters equitable partnerships long before “local ownership” became a policy buzzword. In his own words, the award honors his “career’s contribution to advancing Africa’s health sovereignty” while reinforcing his commitment to ensure younger scientists do not have to fight for legitimacy as previous generations did.
The 2025 Prix Galien Africa celebrated Dr. Makanga alongside innovators reshaping African science. La Ruche Health, a Côte d’Ivoire-based digital health platform, won for connecting users to certified providers through an AI-powered system. Senegalese computer scientist Adji Bousso Dieng received a special prize for applying artificial intelligence to the natural sciences, including spotting emerging viral variants using her “Vendi Score” tool. The awards were organised with the support of the Presidency of Senegal, the Gates Foundation, the West African Health Organization, and the Rockefeller Foundation, with a jury co-chaired by Dr. John Nkengasong and Professor Souleymane Mboup.
Yet the award’s true weight lies not in ceremony, but in its symbolism. Dr. Makanga’s career exemplifies how African scientists can lead, shape policy, and influence global health priorities when empowered and supported.
L-R: La Ruche Health (Côte d’Ivoire) innovator, President of Senegal, Bassirou Diomaye Faye, Dr Michael Makanga (Uganda) and Adji Bousso Dieng (Senegal)
Makerere University colleagues attest to this impact. Dr. Victoria Nankabirwa, a clinical researcher and epidemiologist, reflects: “EDCTP support allowed me to build multidisciplinary teams, enhance laboratory and trial infrastructure, and generate evidence relevant for policy and practice. It strengthened my scientific independence and expanded the long-term sustainability of my research, particularly on childhood vaccines.”
She adds, “Dr. Makanga’s vision and commitment have strengthened institutions, built capacity, and fostered equitable partnerships, enabling African investigators to lead complex studies that address the continent’s priorities. His recognition shows what is possible when scientists are empowered, trusted, and supported.”
Dr. Alex Kayongo, an immunologist at Makerere University, describes EDCTP support as “catalytic,” enabling advanced training and a platform to study microbiome–immune interactions in HIV-associated COPD. His work is shaping mechanistic insights and strengthening Uganda’s capacity for complex respiratory immunology research. “Global health funding is increasingly competitive, making EDCTP’s role even more vital,” he says. “Africa needs sustainable support for complex, lab-intensive research. Continued investment in infrastructure, leadership, and fair partnerships is essential if African institutions are to drive innovation and secure true scientific sovereignty.”
Dr. David Musoke, an associate professor of disease control, credits his EDCTP fellowship with deepening his malaria research and advancing his career. His studies combined housing improvements, environmental management, and behavioural measures to complement traditional malaria prevention, shaping practical, community-informed interventions. “Dr. Makanga’s contribution to African science has been tremendous, and his continued stewardship gives us confidence that evidence generated on the continent will increasingly shape policy and practice,” he observes.
Dr. Makanga’s impact is visible not only in individual careers but across institutions and nations. Through EDCTP, he has championed African-led trials, strengthened laboratory capacity, and fostered cross-country collaboration. Colleagues emphasize that his leadership has created a generation of African scientists who are confident, collaborative, and globally competitive.
“My experience with EDCTP-funded programmes has shown the transformative impact of African-led research,” Dr. Nankabirwa reflects. “Dr. Makanga’s vision and commitment have strengthened institutions, built capacity, and fostered equitable partnerships, enabling African investigators to lead complex studies that address the continent’s priorities. His recognition shows what is possible when scientists are empowered, trusted, and supported, inspiring the next generation of research leaders.”
Dr. Makanga’s recognition is a tribute to perseverance, vision, and mentorship: a scientist who kept going when resources were scarce, a leader who refused partnerships that treated Africans as subjects, and a mentor who reminded young researchers that they belong at the centre of global science.
As he stood among Africa’s leading innovators in Dakar, the message was unmistakable: Africa can lead, Africa must lead, and it will lead, through science, excellence, and equity.
Makerere University is proud to celebrate Dr. Michael Makanga, one of its distinguished alumni, on receiving the Special Career Achievement Prize of the Prix Galien Africa 2025. This honor recognises his exceptional leadership in medical research and his role in advancing African-led science. Through his work, Dr. Makanga continues to strengthen institutions, mentor emerging researchers, and amplify Africa’s voice on the global health stage.
Kalangala, an idyllic archipelago often romanticised for its sunsets, today witnessed a historic leap in healthcare. Makerere University Vice Chancellor, Prof. Barnabas Nawangwe, launched the Infectious Diseases Institute (IDI) Kalangala Clinical Research Centre—the island’s first modern research facility.
“This is more than a building; it’s a lifeline,” said Prof. Nawangwe. “IDI is not only Uganda’s leading health partner, managing over 20% of HIV cases, but research is first on its agenda. If people are not healthy, they can’t work—it’s useless to invest in anything else.”
Prof. Nawangwe unveils the Kalangala Facility plaque.
Kalangala ranks third in HIV prevalence nationwide at 13.1%, with fishing communities hardest hit. Until now, residents endured perilous boat rides to the mainland for advanced care. “Accessing healthcare has always meant a journey across waves—long, costly, and sometimes dangerous,” said District Chairperson Jajab Ssemakula. “You have not only invested in Kalangala; you have brought Makerere University to Kalangala.”
Supported by the Gates Foundation, the centre is part of a multinational HIV prevention study conducted across 31 sites in Kenya, South Africa, and Uganda. Its first mission: testing whether a monthly pill can protect adolescent girls and young women from HIV—a breakthrough that could transform vulnerable communities.
Prof. Barnabas Nawangwe addresses guests.
“This centre means access without barriers,” said Dr. Andrew Kambugu, IDI Executive Director. “Kalangala residents no longer need to travel long distances for clinical trials or advanced care.”
Dr. Andrew Kambugu.
Prof. Samuel Luboga, IDI Board Chairperson, reassured residents of IDI’s long-term commitment: “We are not a fleeting partner. This sentinel research centre aligns with our vision of freeing Africa from the burden of infectious diseases. The assurance I give Kalangala is—we are here to stay.”
Officials pose for a group photo shortly after the facility’s launch.
Henry Ssebunya, Deputy Resident District Commissioner, praised IDI’s innovation and consistency: “IDI has treated and cared for people living with HIV, deployed medical drones to deliver life-saving medicines, and now built a research centre. This is a new chapter for Kalangala.”
Prof. Nawangwe and other officials receive a guided tour of the facility.
From a sleeping sickness camp in 1906 to a cutting-edge research hub in 2025, Kalangala’s story is one of resilience, innovation, and hope.
“Makerere University Infectious Diseases Institute (IDI) Kalangala Clinical Research Centre, Officially inaugurated on 20th November 2025 by Prof. Barnabas Nawangwe, Vice Chancellor, Makerere University with funding from Gates Foundation.”